Cloud-clone
SKU:LMA213Mu
Magnetic Luminex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc.
Magnetic Luminex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc.
Couldn't load pickup availability
Product No.
LMA213Mu
Organism Species
Mus musculus (Mouse).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.98-1000pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.327 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc..
No significant cross-reactivity or interference between Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 91-99 | 95 |
| EDTA plasma(n=5) | 95-102 | 99 |
| heparin plasma(n=5) | 79-91 | 88 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 78-96% | 91-99% | 81-103% | 89-102% |
| EDTA plasma(n=5) | 89-99% | 91-99% | 82-101% | 94-101% |
| heparin plasma(n=5) | 78-96% | 93-105% | 93-101% | 97-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:TREM1) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages Aspet: 171462 |
| Arthritis Research & Therapy | Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. pubmed:27624724 |
| Chinese medical journal | Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8+ T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis PMC5443028 |
| Journal of Maternal-Fetal & Neonatal Medicine | Increased TLR4 and TREM-1 expression on monocytes and neutrophils in preterm birth: further evidence of a proinflammatory state Pubmed:29534643 |
| Journal of Maternal-Fetal & Neonatal Medicine | A promising novel biomarker for early-onset preeclampsia: soluble trigger receptor expressed on myeloid cells-1 (sTREM-1) Pubmed: 33207989 |
| Ioannis Gkougkourellas, Alexandros Sarantopoulos, Konstantinos Tselios, Athanasios Kalogeridis |
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA213Mu01 | Recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA213Mu02 | Recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA213Mu02 | Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) | WB; IHC; ICC; IP. |
| PAA213Mu01 | Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) | WB; IHC; ICC; IP. |
| SEA213Mu | ELISA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA213Mu | Magnetic Luminex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
